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a b s t r a c t
The study of molecular regulation in neural development provides information to understand how
diverse neural cells are generated. It also helps to establish therapeutic strategies for the treatment of
neural degenerative disorders and brain tumors. The Hairy/E(spl) family members are potential targets
of Notch signaling, which is fundamental to neural cell maintenance, cell fate decisions, and compart-
ment boundary formation. In this study, we isolated a zebraﬁsh homolog of Hairy/E(spl), her2, and
showed that this gene is expressed in neural progenitor cells and in the developing nervous system. The
expression of her2 required Notch activation, as revealed by a Notch-defective mutant and a chemical
inhibitor, N-[N-(3,5-diﬂuorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT). The endogenous
expression of Her2 was altered by both overexpression and morpholino-knockdown approaches, and the
results demonstrated that Her2 was both necessary and sufﬁcient to promote the proliferation of neural
progenitors by inhibiting the transcription of the cell cycle inhibitors cdkn1a, cdkn1ba, and cdkn1bb. Her2
knockdown caused premature neuronal differentiation, which indicates that Her2 is essential for
inhibiting neuronal differentiation. At a later stage of neural development, Her2 could induce glial
differentiation. The overexpression of Her2 constructs lacking the bHLH or WRPW domain phenocopied
the effect of the morpholino knockdown, demonstrating the essential function of these two domains and
further conﬁrming the knockdown speciﬁcity. In conclusion, our data reveal that Her2 promotes
progenitor proliferation and maintains progenitor characteristics by inhibiting neuronal differentiation.
Together, these two mechanisms ensure the proper development of the neural progenitor cell pool.
& 2014 Elsevier Inc. All rights reserved.
Introduction
In the developing central nervous system, neural progenitor cells
in the ventricular zone of the neural plate proliferate extensively. The
early stages of neural development are characterized by symmetric
cell division and are followed by asymmetric cell division. Each
asymmetric cell division generates one new progenitor cell and one
neuronal precursor to give rise to different types of neurons. This is
followed by the formation of glial precursors and the differentiation
of glial derivatives. The generation of these diverted neural cells
requires numerous gene regulatory and signaling processes. As such,
understanding this during development may provide important
implications for the development of repair therapies for the treat-
ment of nervous system injuries and tumors. Recent studies demon-
strated that Hairy and Enhancer-of-split [Hairy/E(spl)] genes play
critical roles in maintaining the undifferentiated state of neural
progenitors in addition to regulating neurogenesis and gliogenesis.
Hairy/E(spl) proteins are transcription factors belonging to the basic
helix–loop–helix (bHLH) superfamily and are structurally related to
the Drosophila Hairy and Enhancer-of-split proteins. Seven Hairy/
E(spl) homologs have been identiﬁed in mammals (HES1–7), each of
which contains a conserved bHLH domain that facilitates dimer
formation (HLH region) and DNA binding (basic region). The carboxyl
terminus contains another highly conserved motif, the Trp-Arg-Pro-
Trp (WRPW) domain, which functions as a transcriptional repression
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domain by recruiting the co-repressors Groucho/TLE/Grg (Kageyama
et al., 2008).
Hairy/E(spl) proteins are major downstream targets of Notch
signaling, and they suppress the expression of proneural genes,
such as Neurogenin1 (Neurog1) and Achaete–scute complex homolog
1 (ASCL1) (Louvi and Artavanis-Tsakonas, 2006). Alternatively, they
form heterodimers with ASCL1 to inhibit transcriptional activity,
resulting in the inhibition of neuronal differentiation. Indeed,
neural progenitor cells deﬁcient in HES1 and HES5 expression
cause these cells to prematurely differentiate into neurons and
become depleted without giving rise to the later-born cell types
(Ohtsuka et al., 1999). Therefore, Hairy/E(spl) homologs inhibit
neurogenesis and maintain neural stem/progenitor cells until later
stages to ensure that sufﬁcient numbers of cells with a full cell-
type diversity are generated (Kageyama et al., 2007). Mouse HES1
and HES5 also regulate glial differentiation (Furukawa et al., 2000;
Ohtsuka et al., 2001) and the choice of astrocyte versus oligoden-
drocyte differentiation in glial precursors (Wu et al., 2003). In
zebraﬁsh, more than 15 Hairy/E(spl) homologs have been identi-
ﬁed and named Her [zebraﬁsh homolog of Hairy/E(spl) related]
(Sieger et al., 2004). Among these, Her3, Her4.1, Her5, Her8a, Her9,
and Her11 have been shown to repress proneural or neuronal
genes. Expression of her3 and her5 is repressed by Notch activa-
tion, whereas expression of her4, her6, and her8a is induced by
Notch signaling; on the other hand, expression of her9 is inde-
pendent of Notch activation (Bae et al., 2005; Chung et al., 2011;
Geling et al., 2004; Hans et al., 2004; Ninkovic et al., 2005; Takke
and Campos-Ortega, 1999).
In the present study, we demonstrated that her2 is expressed in
neural progenitor cells and neural derivatives and is regulated by
Notch signaling. We altered the endogenous expression of Her2
using overexpression and morpholino-knockdown approaches
and showed that the gene regulates the proliferation of neural
progenitors and differentiation of neuronal and glial cells. The
effect of the morpholino knockdown was phenocopied by the
overexpression of dominant-negative her2 constructs. Our data
identiﬁed Her2 as a critical transcription factor in the formation of
neural progenitors and neural derivatives. In addition, our data
provide further insights into the roles of Hairy/E(Spl) homologs in
neural development and their response to Notch signaling.
Materials and methods
Ethics statement
All experiments were performed in strict accordance to stan-
dard guidelines for zebraﬁsh work and approved by the Institu-
tional Animal Care and Use Committee of Chang Gung University
(IACUC approval number: CGU08-86 and CGU11-118).
Fish maintenance and mutants
Tü (wild type) zebraﬁsh embryos were purchased from the
Zebraﬁsh International Resource Center (ZIRC, Oregon, USA) and
were raised, maintained, and paired under standard conditions.
The embryos were staged according to the number of somites,
hours post fertilization (hpf), and days post fertilization (dpf)
(Kimmel et al., 1995).
Sequence comparisons
Amino acid sequences were aligned and displayed using the
Vector NTI (Invitrogen). The GenBank accession numbers of the
compared proteins are as follows: zebraﬁsh Her2 (XM_005155921),
Her4.1 (NM_001161408), Her4.2 (NM_131090), Her12 (NM_205619),
Her15.1 (NM_182875), mouse HES5 (NM_010419.4), and human
HES5 (NM_001010926).
Construct generation
The open reading frame of zebraﬁsh her2 was PCR ampliﬁed
with high-ﬁdelity Pfu polymerase (Fermentas) and primers (5’–CG
GGATCCCGGCCACCATGGCACCAACTGTCTGCAAAG-3’ and 5’–GCTCT
AGAGCCCAGGGTCTCCACAATCCAT-3’), which were designed accor-
ding to the zebraﬁsh genome database (www.ensembl.org; reference
number ENSDARG00000038205). For the rescue experiment, a dele-
tion construct, in which the ﬁrst 75 nucleotides after the start codon
were deleted, was ampliﬁed by primers (5’–CGGGATCCCGGCCAC-
CATGGCACCAACTGTCTGCAAAG-3’ and 5’–GCTCTAGAGCCCAGGGTCT-
CCACAATCCAT-3’) to avoid the possible binding of her2 morpholinos.
her2ΔbHLH was created with primers (5’–CGGGATCCCGGCCACCATG-
CATGCGCGGAGCTACTCGG-3’ and 5’–GCTCTAGAGCCCAGGGTCTCCA
CAATCCAT-3’), whereas her2ΔWRPW was made by primers (5’–CGGG-
ATCCCGGCCACCATGGCACCAACTGTCTGCAAAG-3’ and 5’–GCTCTA-
GAGCCAATCCATGCTTGGCGATTTCTG-3’). her2 MO1 and MO2 binding
sequences were inserted upstream of an enhanced green ﬂuorescent
protein reporter in the pCS2 vector to create a 5’her2-EGFP construct
to evaluate the speciﬁcity and efﬁciency of morpholinos.
RNA and morpholino injection
Capped RNA encoding the full coding sequence of her2, her2ΔbHLH,
and her2ΔWRPW were prepared as described previously (Chung et al.,
2011). Antisense morpholino oligonucleotides were purchased from
Gene Tools, LLC (Oregon, USA). Two morpholinos against her2 were
used: MO1 (TGCCATTGCTGCTGTGTTTATGTGC) and MO2 (CTGGAAA-
GAGAAGGTAAAAGTTTGG). Blast analysis revealed a homology of less
than 20-bp identity for MO1 or MO2 to other genomic sequences,
none of which corresponded to 5’ UTR or exon-intron splicing site
of predicted or characterized genes, suggesting that MO1 and MO2
act speciﬁcally on her2. A control morpholino designed to a random
sequence of nucleotides not found in the zebraﬁsh genome
(5’–CCTCTTACCTCAGTTACAATTTATA-3’; Gene Tools) and a morpho-
lino with ﬁve bases mismatch to MO2 (5’-CTaGAAAaAGAAGa-
TAAAAaTTTaG-3’; mismatched bases are indicated by small letters)
were injected in an equal amount of MO1 as a control experiment. All
injections were performed at the one- to two-cell stage, and cRNAs or
morpholinos were introduced into blastomeres. For rescue experi-
ments, embryos were ﬁrst injected with the her2 morpholino and
then with the her2 cRNA using a separate needle to ensure that the
morpholino was effective.
Chemical treatment
Notch signaling was inactivated by DAPT (EMD Millipore)
treatment. DAPT was dissolved in dimethyl sulfoxide to prepare
a 10-mM stock solution. The stock solution was added to the
embryos in order to reach a ﬁnal concentration of 100 μM DAPT.
The control embryos were treated with an identical amount of
dimethyl sulfoxide (DMSO).
Histological analysis
Digoxigenin-UTP labeled riboprobes were synthesized accord-
ing to manufacturer’s instructions (Roche), and in situ hybridiza-
tions were performed as described previously (Cheng et al., 2012).
The color reaction was carried out using NBT/BCIP substrate
(Roche). For immunohistochemistry, the embryos were blocked
in 5% goat serum and incubated with rabbit phosphohistone H3
antibody or rabbit monoclonal anti-active caspase-3 (1:200,
Abcam). Goat anti-mouse IgG HRP or goat anti-rabbit IgG HRP
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(Roche) was used to detect the primary antibodies, and DAB was
used as a substrate for secondary antibody-conjugated HRP
(Amresco). Embryos were mounted with Vectashield mounting
medium (Vector Laboratories, Inc.).
Chromatin immunoprecipitation (ChIP) and PCR
The full coding sequence of her2 was inserted into a pCS2-MT
vector that contained six repeats of Myc-tag. Zebraﬁsh embryos at
the one-cell stage were injected with her2-myc cRNA for the ChIP
analysis. ChIP was performed on 75% epiboly zebraﬁsh embryos
according to previously described methods (Lindeman et al., 2009)
with an anti-Myc tag antibody (EMD Millipore). In general, the
embryos were manually dechorionated and ﬁxed with formalde-
hyde. The unreacted formaldehyde was quenched by glycine, and
the chromatin was isolated and precipitated by a Magna ChIP™ A/G
Chromatin Immunoprecipitation Kit (EMD Millipore). The isolated
chromatin was sonicated to an average size of about 300 bp. Protein
A/G magnetic beads were then added to the chromatin solution and
incubated with an antibody against Myc at 4 1C overnight (2.5 μg of
antibody for each immunoprecipitation experiment). In each ChIP
experiment, a portion of the chromatin solution corresponding to
1% of that used in the ChIP reaction was used as an input DNA
control. The protein A/G bead-antibody/chromatin complex was
pelleted with a magnetic separator, and the Protein/DNA Complexes
were recovered by Elution buffer. DNA was puriﬁed with a poly-
propylene spin column after immunoprecipitation. Immunopreci-
pitated DNA and input DNA were used as templates for PCR
ampliﬁcation, and the primers are listed in Supplementary Table 1.
Quantitative analysis
For quantitative real-time PCR (qPCR), embryos were homo-
genized in TRIzol reagent (Invitrogen), and total RNAwas extracted
using a standard method. cDNA was synthesized from total RNA
with random hexamer priming using RevertAid First Strand cDNA
Synthesis Kit (Fermentas). qPCR was performed on an ABI Ste-
pOne™ Real-Time PCR System (Applied Biosystems) with SYBR
green ﬂuorescent label (Fermentas). Primers for neurogenein1
(F: 5’–CGCACACGGATGATGAAGACTCGCG-3’;
R: 5’–CGGTTCTTCTTCACGACGTGCACAGTGG-3’), deltaA (F: 5’–ACC
GGGTGAAGCTTGTGAAC-3’; R: 5’–CGTCATGCYCGTCCAGAAGTT-3’),
elavl3 (F: 5’–ACTGAGGAGTGGTATCGCTCAAA-3’; R: 5’–AGACCCACGGA-
GAGATTCCA-3’), cdkn1a (F: 5’–GGTGTTCCTCAGCTCCTGTTT-3’; R:
5’–CGGCCCATTACCGAGTGAAC-3’), cdkn1ba (F: 5’–AAAAGTGCGCGTC
TCCAATG-3’; R: 5’–CCGTACATCCTTGGCGAACT-3’), cdkn1bb (F: 5’–
CGGGAATCACGACTGTAGGG-3’; R: 5’–GGGTGTCGGACTCAATGGTT-3’),
and gapdh (F: 5’–ACCCGTGCTGCTTTCTTGAC-3’; R: 5’–GACCAGTTT-
GCCGCCTTCT-3’) were used. Gene expression levels were normalized
to gapdh and assessed using the comparative CT (40 cycles) according
to the manufacturer’s instructions (Applied Biosystems).
Statistical analysis was performed by Student’s t-test using
Microsoft Excels 2007. The signiﬁcance level was set at Po0.05.
All reactions were performed in triplicate for each sample.
Results
Characterization of zebraﬁsh her2
A 399-bp sequence encoding a 133-residue peptide of the her2
open reading frame was identiﬁed on the zebraﬁsh genome data-
base and cloned by PCR. The amino-acid sequence of Her2 shows
the structural features of other Hairy/E(spl) family members, parti-
cularly a bHLH domain and a carboxy-terminal WRPW motif. These
similarities imply that Her2 may act as a transcriptional repressor
(Supplemental Fig. 1). The most similar paralogs of the zebraﬁsh
Hairy/E(spl) subfamily are Her4.1, Her4.2, Her 12, and Her15, which
belong to the Hes5 subgroup (36%, 36%, 43%, and 42% identity to
Her2, respectively) (Chung et al., 2011). Compared with other
orthologs of the Hairy/E(spl) family, Her2 showed the highest degree
of similarity to mouse and human HES5, with 50% identical amino
acids. Within the bHLH domain, the identity increases to 71%.
her2 is expressed in the developing nervous system
The expression of her2 was analyzed by whole-mount in situ
hybridization. Transcripts ﬁrst appeared in the developing nervous
system at the 75% epiboly stage in the neuroectoderm (Fig. 1B). The
expression of her2 in the neuroectoderm was further analyzed by
counterstaining with the neural progenitor marker sox2. This demon-
strated their overlapping expression (Fig. 1C D) and indicated that
her2 was expressed in neural progenitors. At the bud stage, a strong
expression of her2 was detected in the primordium of brain and
proneuronal domains representing neuronal precursors and the
midbrain-hindbrain boundary (Fig. 1E and Supplemental Fig. 2). From
the midsegmentation stages, the cells with different levels of expres-
sion of her2 spanned the entire central nervous system (Fig. 1F I).
At the 8-somite stage (13hpf), strong her2 expression was retained in
the dorsal telencephalon, ventral midbrain, hindbrain, and spinal cord
(Fig. 2F G). In the hindbrain, her2 expressionwas observed in all of the
rhombomeres at different levels (Fig. 1F G). At the 18-somite stage
(18 hpf), her2 was expressed in the entire forebrain, with relatively
weak expression retained in the midbrain and segmented expression
in the hindbrain (Fig. 1H I). At 24 hpf, strong her2 signals were
detected in many structures in the telencephalon (see ﬁgure legend
for details), and the expression in the hindbrain was now widespread
without a clear segmented pattern. Strong signals were also observed
in the developing cerebellum at this stage (Fig. 1J K). By the late
pharyngula stages (48 hpf), the expression of her2 was weak in the
spinal cord and was mainly restricted to the brain, notably in the
tectum and dorsal hindbrain (Fig. 1L M). In addition to the nervous
system, the expression of her2 was detected in the presomitic
mesoderm from the bud stage to the 8-somite stage (Fig. 1E, G),
suggesting a role in somitogenesis. The dynamic expression of her2
in neural tissues suggests its importance in central nervous system
development.
her2 is regulated by the delta–notch signaling pathway
In the developing nervous system, Hairy/E(Spl) homologs can
suppress or promote neurogenesis acting in either a Notch-
dependent or Notch-independent manner (Fischer and Gessler,
2007; Kageyama et al., 2007). To examine the response of her2 to
Notch signaling, we analyzed its expression in mind bomb mutant
embryos (mibta52b) that have a strong deﬁciency in the Notch
pathway (Jiang et al., 1996) due to a mutation of a ubiquitin ligase
required for Delta ligand activity (Itoh et al., 2003). Compared
with wild-type embryos, her2 was signiﬁcantly downregulated in
mibta52b embryos (Fig. 2A), suggesting that the expression of her2
requires the activation of Delta–Notch signaling. To further examine
whether the loss of her2 expression in late stages was not a
consequential phenotype caused by defective Notch signaling at
earlier stages, we used the γ-secretase inhibitor, DAPT, which has
been shown to efﬁciently block Notch signaling at different time
points (Geling et al., 2002). Embryos were treated with DAPT at the
shield stage (6 hpf) and harvested at 75% epiboly (8 hpf), at 8 hpf
and harvested at the bud stage (10 hpf), or at 10 hpf and harvested
at 24 hpf. The embryos analyzed at 75% and the bud-stage exhibited
a downregulation of her2 expression in a level similar to the result
obtained frommibta52b mutant (Fig. 2B). In contrast, DAPT treatment
at 10 hpf with embryos harvested at 24 hpf only slightly reduced
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her2 expression compared to that in the mibta52b mutants (Fig. 2B).
This result demonstrated that Notch signaling was essential for her2
expression during early neural development but that the regulation
had lesser effects at later stages (see Discussion).
Her2 knockdown causes developmental abnormalities
To delineate the role of Her2 during embryonic development, the
morpholino-knockdown approach was used to decrease the expres-
sion of Her2. To block protein production, two 25-bp antisense
morpholinos (MO1 and MO2) were synthesized to target different
regions located adjacent to the translation start site of her2 mRNA.
The speciﬁcity of morpholinos was conﬁrmed by rescue experiments
in which the morpholinos were co-injected with cRNA for her2, as
described for each experiment below. To conﬁrm the efﬁcacy of the
morpholino-knockdown approach, each of the two her2 morpholi-
nos was co-injected with cRNA of a reporter construct that con-
tained the her2 MO1 and MO2 binding sequences upstream of an
enhanced green ﬂuorescent protein reporter (50her2-EGFP). Effective
knockdown, as revealed by the loss of the EGFP protein, was
observed upon co-injection with either of the two her2morpholinos,
whereas no reduction in EGFP protein expression was observed
upon co-injection with a control morpholino (Fig. 3A).
Embryos injected with MO1 or MO2 were analyzed for mor-
phological defects at 24 hpf and two days post-fertilization (dpf).
Injection of 4.3 ng of MO1 or 2.16 ng of MO2 resulted in identical
Fig. 1. The expression of her2 in developing zebraﬁsh embryos. (A) Schematic illustration of a gastrula stage embryo in lateral view. Prospective epidermis (epi) is green;
prospective nervous system (neuro) is blue. an, animal pole; D, dorsal; V, ventral; ve, vegetal pole. (B-M) In situ hybridization analysis of the expression of her2 in the
developing nervous system. (C-D) A coronal section of the her2-stained neural ectodermal region (as marked in B) with the double in situ hybridization for her2 (purple) and
sox2 (red) and that shows overlapping expression. The expression of her2was detected by NBT/BCIP and sox2was detected by Fast Red. The stages of the embryos are shown
in the bottom left corner of each panel. (B, E, G, I, K, and M) Dorsal views, with anterior to the left. (F, H, J, and L) Lateral view, anterior to the left. Arrows in E indicate her2
expressing cells in the proneuronal domains. The square bracket in J indicates the zona limitans intrathalamica (zli). Abbreviations: ce, cerebellum; dt, dorsal telencephalon;
hb, hindbrain; mb, midbrain; mhb, midbrain-hindbrain boundary; psm, presomitic mesoderm; sc, spinal cord; tec, tectum; tel, telencephalon; th, thalamus; vt, ventral
telencephalon; vpt, ventral-posterior telencephalon.
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phenotypes; therefore, only embryos injected with 2.16 ng of MO2
are shown (see Supplementary Fig. 2 for the phenotypes of both
morpholinos). Her2 knockdown resulted in severe defects, includ-
ing brain malformations, such as an irregularly folded structure
and enlarged third and fourth brain ventricles, a bent trunk, and
edema in the pericardial chamber and fourth ventricle. Notably,
the morphology of the midbrain-hindbrain boundary was not
affected (Fig. 3B). The phenotypes caused by morpholino injection
were rescued by concomitant injection of her2 mRNA, indicating
that the morpholino-induced defect was speciﬁcally due to the
loss of Her2 function (Fig. 3B).
Her2 induces the proliferation of neural progenitors
We ﬁrst analyzed the role of Her2 in neural progenitor cells.
A previous study has demonstrated that Sox2 is expressed in neural
stem/progenitor cells where it maintains the stemness identity and
inhibits neurogenesis (Lefebvre et al., 2007). We found that the
expression of sox2 was signiﬁcantly downregulated following Her2
knockdown (Fig. 4A). To conﬁrm this, we used sox3 as an additional
neural progenitor marker (Okuda et al., 2006; Shih et al., 2010) and
found that the expression of sox3 also decreased in Her2 morphants
(Fig. 4A). These results were conﬁrmed by quantitative real-time PCR
(qPCR), which revealed a 0.5- and 0.6-fold decrease in sox2 and sox3,
respectively (Fig. 4C). We further analyzed the proliferating progeni-
tors using a phosphohistone H3 antibody and sox2 counterstaining.
The result revealed signiﬁcantly decreased neural progenitor pro-
liferation (Fig. 4E, G). Co-injection with her2 cRNA attenuated the
morpholino effects (Fig. 4), indicating that the neural defects in Her2
morphants were due to the speciﬁc inhibition of Her2 function.
These results demonstrated that Her2 is required for the prolifera-
tion of neural progenitors.
The loss of sox2- or sox3-positive neural progenitors could be
explained by either decreased proliferation or induced apoptosis.
Therefore, we examined cell apoptosis using immunohistochemis-
try to detect the presence of activated caspase-3. No signiﬁcant
differences were observed between her2 morphants and controls
(data not shown), suggesting that Her2 does not participate in
neural progenitor apoptosis.
Previous studies have shown that morpholinos can cause off-
target apoptosis mediated by p53 activation (Robu et al., 2007). To
rule out this possibility, all the her2 MOs were co-injected with a
tp53MO. The results revealed no signiﬁcant differences between the
phenotypes of embryos co-injected with her2 and tp53 MOs and
those injected with her2 MO alone (Supplemental Fig. 3). Because
the phenotypes resulting from her2 morpholino injection were also
rescued by concomitant injection of her2 cRNA (as noted above), the
phenotypes of the her2morphants did not result from p53 activation
but rather resulted from the speciﬁc inhibition of Her2 function.
We next examined whether Her2 is sufﬁcient to induce neural
progenitor proliferation. The overexpression of her2 cRNA in zebra-
ﬁsh embryos resulted in increased expression of sox2 and sox3
(Fig. 4B, D). Counterstaining of sox2 with phosphohistone H3 reve-
aled an increased number of proliferating neural progenitors in
embryos injected with her2 (Fig. 4F, H). This observation was further
conﬁrmed by counting the proliferating cells in the sox2-positive and
sox2-negative populations, which showed that disrupted her2
expression did not cause signiﬁcant effects on the proliferation of
non-neural ectodermal cells (Fig. 4G, H). This result suggested that
Her2 is sufﬁcient to induce the proliferation of neural progenitors.
Previous studies have shown that mouse HES1 represses the
transcription of the cell cycle inhibitors Cdkn1a (encoding p21cip1)
(Castella et al., 2000) and Cdkn1b (encoding p27Kip1) (Murata et al.,
2005). Therefore, we analyzed the expression of these cell cycle
regulators to examine the mechanism by which Her2 induced neural
progenitor proliferation. Two Cdkn1b paralogs, named cdkn1ba (pre-
viously named cdkn1bl) and cdkn1bb (previously named cdkn1b),
exist in the zebraﬁsh genome. The results of qPCR analyses demon-
strated that the expression of cdkn1a, cdkn1ba, and cdkn1bb were
downregulated by her2 cRNA injections. In contrast, injection of her2
morpholino caused upregulation of cdkn1a, cdkn1ba, and cdkn1bb
expression (Fig. 5A). This result indicated that Her2 regulates cell
proliferation by inhibiting the transcription of these cell cycle inhi-
bitors and consequently promotes cell cycle progression.
We performed a ChIP analysis in order to conﬁrm the direct
binding of Her2 to the promoters of cdkn1a, cdkn1ba, and cdkn1bb.
We tagged Her2 with a Myc-tag and used an antibody against Myc
in the ChIP assays on extracts from 75% epiboly embryos. Follow-
ing the injections of her2-myc cRNA into fertilized eggs, we
detected high Myc levels (data not shown), and the chromatin
fragments that were isolated from these embryos were immuno-
precipitated with an antibody against the Myc-tag. Previous
studies have shown that mouse HES1 directly binds to speciﬁc
DNA sequences called N-boxes, which are also known as class C
sites, in the promoter regions of target genes (Sasai et al., 1992;
Takebayashi et al., 1994). Through direct sequence comparison, we
identiﬁed several N-boxes in the promoters of cdkn1a, cdkn1ba,
and cdkn1bb, and designed PCR primers accordingly (Fig. 5B)
to investigate if the fragments from the ChIP were selectively
ampliﬁed. The results revealed that Her2 bound to numerous
N-boxes in the promoters of cdkn1a, cdkn1ba, and cdkn1bb
(Fig. 5C). Taken together, the results demonstrated that Her2
repressed the transcription of cdkn1a, cdkn1ba, and cdkn1bb by
directly binding to the N-boxes of the promoter regions.
We further examined whether Her2 regulated neural pattern-
ing. Although altering Her2 expression affected the proliferation of
Fig. 2. The expression of her2 is lost in Notch-deﬁcient embryos. (A) The expression
of her2 was analyzed in mibta52b homozygous mutants and wild-type siblings by
in situ hybridization. The stages are shown in the bottom left corner. Left and right
panels are lateral views, and the middle panels are dorsal views. The arrows
indicate her2 expression in the neural progenitor cells. (B) DAPT treatment was
performed at different time points, and the embryos were harvested at different
stages as indicated, showing that DAPT treatment caused a downregulation of her2
expression.
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sox2-positive cells, altering Her2 expression did not show a
signiﬁcant disruption in the size of sox2-expressing domains
(Fig. 4I, J). We examined the patterning markers otx2 and zic2b
(Okuda et al., 2010) and found that otx2 and zic2b expression was
downregulated by her2 MO and upregulated by her2 cRNA injec-
tions; notably, the size of the otx2 or zic2b expression domain was
not signiﬁcantly altered (Supplementary Fig. 5). These results,
taken together with the results that Her2 induced sox2 expression
as shown above, suggested that Her2 regulated the formation of
neural progenitors without affecting neural patterning. We con-
ﬁrmed that Her2 did not regulate neural versus epidermal fate
decisions by analyzing the surface-ectodermal marker tp63 and
showed that altering her2 expression had no signiﬁcant effects on
the expression of tp63 (Supplementary Fig. 5).
Her2 is required for the inhibition of neuronal differentiation
After the formation of neural progenitors, the next step in
neurogenesis is the speciﬁcation of neuronal precursors within the
neurogenic region, which is regulated by proneural genes. The
expression of her2 in the proneuronal domain prompted us to
examine the role of Her2 in neuronal precursors. We found that
the expression of the proneural markers neurog1, deltaA, ascl1a,
and ascl1b was dramatically downregulated in the morpholino-
injected embryos. We used in situ hybridization and qPCR and
determined that this phenotype was rescued by the concomitant
injection of her2 cRNA (Fig. 6A, B).
The decreased expression of these neuronal precursors could
be a result of the Her2 knockdown-mediated loss of sox2- or
sox3-positive neural progenitors (as described above). However,
because many Hairy/E(Spl) proteins act as transcriptional repres-
sors of genes responsible for neurogenesis, the loss of proneural
gene expression could also be due to premature differentiation of
neurons caused by the loss of Her2-mediated inhibition of neuro-
nal differentiation. Accordingly, we analyzed the effect of Her2
knockdown using a post-mitotic neuronal marker, elavl3 (encod-
ing HuC) (Takamiya and Campos-Ortega, 2006). elavl3 transcripts
were not detectable at the bud stage in wild-type embryos and
were detected only in the 3-somite stage, reﬂecting the beginning
stage of neuronal differentiation. In contrast, a signiﬁcant amount
Fig. 3. Knockdown of Her2 causes developmental abnormalities. (A) Embryos co-injected with 50her2-EGFP cRNA and control morpholino showed strong expression of EGFP
(left panel). In contrast, the EGFP signal was abolished in embryos co-injected with 50her2-EGFP cRNA and her2 MO1 (right panel). (B) Representative images of morpholino-
injected embryos. The asterisks denote edema in the fourth ventricle. Brain malformation is marked by arrows. These morphological phenotypes can be rescued by
concomitant injection with 2 ng her2 cRNA. The bottom panels are the enlarged brain regions of the upper panels. Note that the structure of the midbrain-hindbrain
boundary was unaffected by the her2 morpholino (arrowheads).
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Fig. 4. Her2 regulates neural progenitor proliferation. (A) The expression of neural progenitor markers sox2 and sox3 was downregulated in Her2-knockdown embryos and
was rescued by co-injection with her2 cRNA. (B) her2 induced the expression of sox2 and sox3. (C and D) The results of in situ hybridization in A and B were quantitatively
conﬁrmed by qPCR analysis, respectively. (E, F) Proliferation of neural progenitors was detected by in situ hybridization using a sox2 riboprobe (purple) and counterstaining
with phosphohistone H3 antibody (brown). The bottom panels are representative of the enlarged regions of the upper panels, as indicated. (G, H) The proportions of the
phosphohistone H3- and sox2-positive cells among the total sox2-positive cells were quantiﬁed (left panels in G and H), showing that Her2 knockdown resulted in the
decreased proliferation of sox2-positve neurons (left panel in G) and that her2 cRNA induced the proliferation of sox2-positive neurons (left panel in H). The right panels in G
and H show the quantiﬁcation of the proportions of phosphohistone H3-positive and sox2-negative cells in sox2-negative cells that were counted in the adjacent surface
ectoderm, which showed no signiﬁcant deviation in Her2-distorted embryos. (I, J) The sox2-positive region was quantiﬁed by ImageJ. All panels show embryos at 75%
epiboly. pH3, phosphohistone H3; n, po0.05; nn, po0.01; n.s., not signiﬁcant.
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of elavl3 transcripts was observed in Her2-knockdown embryos at
the bud stage, concurrent with reduced neurog1-positive neuronal
precursors (Fig. 6A, B). This indicates that neurons prematurely
differentiated from deltaA- or neurog1-positive precursors into
elavl3-positive differentiating neurons. The effect of her2 morpho-
lino could be attenuated by co-injection with her2 cRNA but not
tp53 morpholino (Fig. 6A, B and Supplemental Fig. 3). Intriguingly,
the overexpression of her2 cRNA alone did not alter the expression
of proneural markers (Fig. 6C, D), indicating that Her2 alone was
not sufﬁcient to inhibit neurogenesis. Taken together, these results
indicated that Her2 is required for the inhibition of neuronal
differentiation. Furthermore, the loss of neural progenitors and
premature differentiation account for the decreased deltaA- or
neurog1-positive neuronal precursors.
Her2 induces glial differentiation
Gliogenesis proceeds after neurogenesis. It has been shown that
mouse Hes1 and Hes5 not only repress the expression of proneural
genes during neurogenesis but also promote the differentiation of
many glial subtypes (Louvi and Artavanis-Tsakonas, 2006). Consis-
tent with this, we found that the early glial marker, slc1a3a (Glast in
mammals) (Chung et al., 2011; Shibata et al., 1997; Storck et al.,
1992), was reduced in Her2-knockdown embryos (Fig. 7), suggesting
that Her2 is required for gliogenesis. To further conﬁrm that the
reduction of slc1a3a in Her2 morphants was not due to increased
glial differentiation, we analyzed the expression of a mature radial
glial cell marker, gfap. We found that the expression of gfap was
downregulated in Her2-knockdown embryos (Fig. 7), supporting our
notion that Her2 is required for gliogenesis. Widespread overexpres-
sion of her2 cRNA upregulated the expression of slc1a3a and gfap
(Fig. 7), suggesting that her2 was effective in inducing gliogenesis.
Abrogation of the bHLH or WRPW domain in her2 causes a
dominant-negative effect
To gain insight into the structural requirements for Her2
function, we created two deletion variants: one lacking the region
containing the bHLH DNA binding domain up to the amino
terminus of Her2 (her2ΔbHLH) and the other lacking the carboxy-
terminal end, including the WRPW domain (her2ΔWRPW) (Fig. 8A).
Injection of either her2ΔbHLH or her2ΔWRPW resulted in reduced
levels of neural progenitors and neuronal and glial derivatives
(Fig. 8B, C). The phenotypes caused by injection of her2ΔbHLH or
Fig. 5. Her2 inhibits the transcription of cdkn1a, cdkn1ba, and cdkn1bb by direct binding to the promoter region. (A) qPCR quantiﬁcation showing that injection of her2 cRNA
downregulates the expression of cdkn1a, cdkn1ba, and cdkn1bb, whereas injection of her2 morpholino upregulates the expression of cdkn1a, cdkn1ba, and cdkn1bb. n,
po0.05; nn, po0.01; nnn, po0.001. (B) A schematic representation of the promoter region of cdkn1a, cdkn1ba, and cdkn1bb, and fragments containing potential N-boxes are
named and indicated. These fragments were selected for PCR ampliﬁcation. (C) Chromatin immunoprecipitation (ChiP)–PCR analysis was performed on 75% epiboly embryos.
Many fragments (1a-i and 1a-ii of cdkn1a; 1ba-i, 1ba-ii, and 1ba-iii of cdkn1ba; and 1bb-I and 1bb-ii of cdkn1bb) that were ampliﬁed by PCR suggested direct binding of Her2
to these regions.
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Fig. 6. Knockdown of Her2 induces premature differentiation of neuronal precursors. (A) Injection of her2 morpholino downregulated the expression of neurog1, deltaA,
ascl1a, and ascl1b and upregulated the expression of elavl3 at the bud stage. The phenotypes caused by morpholino injection could be rescued by concomitant injection with
her2 cRNA. (B) qPCR analysis conﬁrmed the results obtained by in situ hybridization. (C) Compared with the controls, injection of her2 cRNA did not cause a signiﬁcant
alteration in proneural markers (neurog1, deltaA, ascl1a, and ascl1b). (D) qPCR quantiﬁcation of the results in C. nn, po0.01; n.s., not signiﬁcant.
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her2ΔWRPW were identical to those observed in Her2-knockdown
embryos. These results indicated that both bHLH and WRPW
domains are required for Her2 function and that the deletion of
either domain is sufﬁcient to cause a dominant-negative effect.
These results also conﬁrmed the speciﬁcity of the phenotypes
conferred by her2 morpholino injection.
Discussion
Development of the nervous system with the appropriate num-
bers of neurons and glia requires a proper balance of proliferation
and differentiation to generate neural progenitors and intermediate
precursors. However, the underlying regulatory mechanisms largely
remain to be identiﬁed, particularly because only a few transcription
factors have been shown to be involved in the proliferation and
differentiation of neural stem/progenitor cells. One of the critical
elements for the formation of neural stem/progenitor cells is the
SoxB1 transcription factor family (Kondoh and Kamachi, 2010).
In zebraﬁsh, the members of the SoxB1 family (Sox1, 2, 3, and 19)
are required for the speciﬁcation of neural ectodermal fate and the
maintenance of neural stem cell fate. In combination with the Pou2/
Oct4 transcription factor, Sox2 activates repressors of neuronal
differentiation, such as her3 (Schmidt et al., 2013). Hairy/E(Spl)
transcription factors (Hes or Her) have also attracted much attention
because of their role in inhibiting neuronal differentiation and
maintaining cells in a neural stem/progenitor status. Members of
Hes (Her) genes, such as her3 and Hes5, are transcriptional targets of
SoxB1 (Engelen et al., 2011; Okuda et al., 2010). The ectopic
expression of these Hes/Her proteins results in a downregulation
of neurogenin1 expression, whereas loss-of-function experiments
have shown an increase in neurogenin1 expression. Taken together,
the SoxB1/Hes-dependent active inhibition of neurogenesis is the
crucial mechanism that expands the pool of neural progenitor cells
(Kageyama et al., 2008). However, the instructive role of Hairy/E(Spl)
proteins in neural stem/progenitor cells remains unclear. Recent
studies have shown that Hairy/E(Spl) may directly bind to genes
responsible for the cell cycle. In vitro analysis revealed that the
expression of HES1 repressed the transcription of the cell cycle
inhibitors Cdkn1a (encoding p21cip1) (Castella et al., 2000) and
Cdkn1b (encoding p27Kip1) (Murata et al., 2005). In contrast, Hes1-
deﬁcient embryos showed an elevated expression of Cdkn1b in the
liver and brain (Murata et al., 2005), suggesting that Hairy/E(Spl)
proteins directly regulate cell cycle progression. In this study, we
provided the ﬁrst in vivo evidence showing that a Hairy/E(Spl)
protein, Her2, is required for maintaining the progenitor status by
inhibiting neuronal differentiation and is sufﬁcient to induce the
proliferation of neural progenitors by inhibiting the expression of
cdkn1a, cdkn1ba, and cdkn1bb. These results revealed a novel role of
Hairy/E(Spl) proteins in expanding the neural stem/progenitor
population by promoting the proliferation of neural stem/progenitor
cells and inhibiting neuronal differentiation.
The roles of many Her proteins have been characterized during
embryogenesis. For example, Her1, Her4, Her6, Her7, Her11, Her12,
Her13.2, and Her15 are essential for somitogenesis (Brend and
Holley, 2009; Henry et al., 2002; Pasini et al., 2004; Shankaran
et al., 2007; Sieger et al., 2004). We found that Her 2 was also
expressed in the presomitic mesoderm, thus suggesting a potential
role in somitogenesis, which is worth further investigation. In the
developing nervous system, Her4, which is expressed in the
proneuronal domains, inhibits the expression of neurogenin1 and
reduces neurogenesis (Takke et al., 1999), whereas our results also
showed that Her2 inhibits neuronal differentiation. Given that
both Her2 and Her4 are orthologs of mammalian HES5 and that
HES5 is also essential for the inhibition of neurogenesis (Ohtsuka
et al., 1999), these results suggested an evolutionarily conserved
Fig. 7. Her2 induces glial differentiation. (A) In situ hybridization showing the expression of slc1a3a and gfapwas reduced in Her2-knockdown embryos, whereas injection of
her2 cRNA upregulated their expression. The stages of the embryos are shown in the bottom-left corner. (B) qPCR analysis conﬁrmed the results of in situ hybridization
shown in A. n, po0.05; nn, po0.01; nnn, po0.001.
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role between HES5, Her2, and Hes4 in the inhibition of neuro-
nal differentiation. In contrast, her5 and her11 are speciﬁcally
expressed in the midbrain-hindbrain boundary where they act
as prepattern genes to prevent neurogenesis in the midbrain-
hindbrain boundary (Geling et al., 2003; Geling et al., 2004). Our
results that her2 was also expressed in the midbrain-hindbrain
boundary suggest a role for her2 in the formation of the midbrain-
hindbrain boundary. However, the conformational structure of the
midbrain-hindbrain boundary was unaffected in Her2-knockdown
embryos, suggesting a possible compensatory function of other
Her proteins in the midbrain-hindbrain boundary in Her2 mor-
phants, which remains to be conﬁrmed. Her2 was also expressed
in many speciﬁc brain structures during segmentation stages.
Related to this ﬁnding, her6, which is expressed in the thalamic
complex, determines thalamic neurogenesis and the decision between
glutamatergic and GABAergic fates (Scholpp et al., 2009). Therefore,
whether Her2 is implicated in the formation of brain structures rem-
ains to be discovered.
Hairy/E(Spl) proteins form homodimers or heterodimers with
other Hairy/E(spl) factors, following which they directly bind to their
target proneural genes to repress transcription and inhibit neuronal
differentiation. They also form heterodimers with bHLH activators,
such as ASCL1 and E47, to inhibit their transcriptional activity
(Kageyama et al., 2008). Although we found that the knockdown of
Her2 resulted in premature neurogenesis, which could be rescued by
concomitant overexpression of her2 cRNA, overexpressing Her2 alone
failed to efﬁciently inhibit the formation of neuronal precursors. This
suggests that Her2 needs to form a heterodimer with other Hairy/
E(spl) factors to inhibit neuronal differentiation. The expression of
her2 in the proneuronal domains is similar to that of her4, her8a,
her12, and her15.1 (Bae et al., 2005; Chung et al., 2011), suggesting
that Her4, Her8a, Her12, and Her15.1 are potential heterodimeric
partners for Her2 to facilitate the inhibition of neurogenesis; how-
ever, this remains to be conﬁrmed.
We also revealed Her2 as the ﬁrst Her protein that is sufﬁcient to
induce gliogenesis. In mammals, an aberrant expression of Hes1 or
Hes5 promotes the generation of Müller glia in the retina, whereas
the inactivation of Hes1 or Hes5 causes defects in Müller glial
development (Furukawa et al., 2000; Hojo et al., 2000). However, in
contrast with the retina, the aberrant expression of Hes1 or Hes5 in
the embryonic brain inhibits both neurogenesis and gliogenesis
(Ohtsuka et al., 2001). Therefore, the function of Her2 is not
evolutionarily conserved within the mammalian homologs. Previous
studies have shown reduced neurogenesis and increased gliogenesis
in a double-mutant mouse model of proneural genes Ascl1 and
Neurod4 or Ascl1 and Neurog2, suggesting that proneural genes
regulate neuronal versus glial fate determination (Nieto et al., 2001;
Tomita et al., 2000). Thus, a possible explanation is that Her2
repressed proneural gene expression and consequently induced the
expression of glial markers and reduced proneural markers. However,
Fig. 8. Resemblance between the phenotypes of her2ΔbHLH- or her2ΔWRPW-injected embryos and those of her2 morphants. (A) Schematic illustration of her2ΔbHLH and
her2ΔWRPW deletion constructs. (B) In situ hybridization showing injection of either her2ΔbHLH or her2ΔWRPW was sufﬁcient to downregulate markers for neural progenitors and
neuronal and glial derivatives, as observed in Her2 morphants. The stages of the embryos are shown in the bottom- left corner. These results were conﬁrmed by qPCR (C).
n, po0.05; nn, po0.01.
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we found that Her2 alone was not sufﬁcient to inhibit the expression
of proneural genes but could induce glial differentiation, suggesting
that Her2 plays an instructive role in gliogenesis, independent of its
role in inhibiting neurogenesis. In addition, we found that a Notch
deﬁciency had little effect on the expression of her2 after neurogen-
esis, which raised the question of whether her2 is regulated by Notch
signaling or whether it also responds to other signaling pathways
during gliogenesis. These questions need to be further analyzed.
Conclusion
The Hairy/E(Spl) repressor genes play an essential role in neural
development by maintaining progenitor cells and regulating binary
cell fate decisions; however, their role in neural progenitor cells
remains unclear. We showed that Her2 not only maintains pro-
genitor characteristics by inhibiting neuronal differentiation but
also promotes the proliferation of progenitors by inhibiting the cell
cycle inhibitors. This suggests that Her2 governs these two mechan-
isms to provide the proper development of the progenitor pool.
Her2 also instructively induces glial differentiation. Therefore, Her2
has multiple activities depending on the cell type and develop-
mental stages and is critical for nervous system development.
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